Skip to main content

Table 1 Efficacy of serological markers and imaging modalities in the diagnosis of TA

From: Role of inflammatory markers in Takayasu arteritis disease monitoring

Modality

Sensitivity (%)

Specificity (%)

Citation

ESR

72*

56*

Kerr, Hallahan, Giordano, et al., 1994†,‡[7]

CRP

71.4*

100*

Ishihara, Haraguchi, Tezuka, et al., 2012†,§,¶[21]

FDG-PET

92*

100*

Webb, Chambers, AL-Nahhas, et al., 2004†,‡,§[34]

MRA

100*

100*

Yamada, Nakagawa, Himeno, et al., 2000 [31]

CTA

95*

100*

Yamada, Nakagawa, Himeno, et al., 1998[27]

PTX-3

82.1-89**

87-94.1**

Ishihara, Haraguchi, Tezuka, et al., 2012†,§,¶, [21] Dagna, Salvo, Tiraboschi, et al., 2011†,‡,§[23]

  1. *In diagnosing TA.
  2. **In distinguishing active from inactive disease.
  3. TA diagnosis or disease activity state determined by;
  4. Clinical assessment.
  5. Typical findings on conventional angiography.
  6. §Patients met 1990 American College of Rheumatology criteria for TA diagnosis.
  7. MRA.